Cargando…
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence
Background: As a major cause of morbidity and mortality among men, prostate cancer is a heterogenous disease, with a vast heterogeneity in the biology of the disease and in clinical outcome. While it often runs an indolent course, local progression or metastasis may eventually develop, even among pa...
Autores principales: | Yan, Wusheng, Jamal, Muhammad, Tan, Shyh-Han, Song, Yingjie, Young, Denise, Chen, Yongmei, Katta, Shilpa, Ying, Kai, Ravindranath, Lakshmi, Woodle, Tarah, Kohaar, Indu, Cullen, Jennifer, Kagan, Jacob, Srivastava, Sudhir, Dobi, Albert, McLeod, David G., Rosner, Inger L., Sesterhenn, Isabell A., Srinivasan, Alagarsamy, Srivastava, Shiv, Petrovics, Gyorgy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849651/ https://www.ncbi.nlm.nih.gov/pubmed/31741711 http://dx.doi.org/10.18632/oncotarget.27294 |
Ejemplares similares
-
Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020) -
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014) -
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
por: Rastogi, Anshu, et al.
Publicado: (2016) -
Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014) -
Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)